Without RCT data on semaglutide for the management of BAD, it is difficult to evaluate its safety and efficacy compared with other BAD therapeutics, but the abovementioned case underscores that newer, longer-acting, and more potent GLP-1RAs not necessarily provide better treatment results in BAD as compared with older, shorter-acting, and less potent GLP-1RAs such as liraglutide
Blossom Inuenwi, DNP, provides personalized guidance to help patients understand how GLP-1 medications work and whether a specific approach may align with their health goals and wellness needs
The primary analysis included all patients with at least one follow-up visit after the index date
Glukagon-lik peptid-1, GLP-1, och glukosberoende insulinotropisk polypeptid, GIP, r tv peptidhormoner som fristts i tarmkanalen vid fdointag och spelar en avgrande roll fr aptitreglering, nringsintag, magtmningshastighet och gastrointestinal motilitet
However, lyophilisation does not make the compound invincible
Phentermine vs